Zag Bio Secures $80 Million in Series A Funding

T1D Fund and Polaris Partners lead the investment in the Cambridge-based biotech startup Zag Bio, securing $80 million in Series A funding.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here